Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 1 58-1, 2005, Pages

  Fernando, Anthony N ^a   Fernando, Lawrence P ^a   Fukuda, Yu ^a   Kaplan, Allen P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Kallikrein; Mitogen activated protein kinases; Vascular endothelial cells

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ; BRADYKININ ANTAGONIST; HIGH MOLECULAR WEIGHT KININOGEN; ICATIBANT; KALLIKREIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PREKALLIKREIN; ZINC ION;

ARTICLE; ATHEROSCLEROSIS; BIOTINYLATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLUORESCENCE; HUMAN; HUMAN CELL; KALLIKREIN KININ SYSTEM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

BRADYKININ; CELLS, CULTURED; FACTOR XII; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; KININS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSMOLAR CONCENTRATION; PHOSPHORYLATION; PREKALLIKREIN; SIGNAL TRANSDUCTION; TIME FACTORS; ZINC;

EID: 21644457354     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00206.2004     Document Type: Article

References (34)

1. Bennett MR and Boyle JJ. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138: 3-9, 1998.
2. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993.
3. Douillet CD, Velarde V, Christopher JT, Mayfield RK, Trojanowska ME, and Jaffa AA. Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-β and MAPK. Am J Physiol Heart Circ Physiol 279: H2828-H2837, 2000.
4. Fernando LP, Natesan S, Joseph K, and Kaplan AP. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes. Thromb Haemost 90: 787-795, 2003.
5. Fernando LP, Fernando AN, Joseph K, and Kaplan AP. Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells. J Thromb Haemost 1: 2444-2449, 2003.
6. Galis ZS, Sukhova GK, Lark MW, and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503, 1994.
7. Gimbrone MA Jr. Vascular endothelium and atherosclerosis. In: Vascular Injury and Atherosclerosis, edited by Moore S. New York: Dekker, 1981, p. 25-52.
8. Gordon EM, Venkatesan N, Salazar R, Tang H, Schmeidler-Sapiro K, Buckley S, Warburton D, and Hall FL. Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci USA 93: 2174-2179, 1996.
9. Greengard JS and Griffin JH. Receptors for high molecular weight kininogen on stimulated washed human platelets. Biochemistry 23: 6863-6869, 1984.
10. Griffin JH and Cochrane CG. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc Natl Acad Sci USA 73: 2554-2558, 1976.
11. Gustafson EJ, Schutsky D, Knight LC, and Schmaier AH. High molecular weight kininogen binds to unstimulated platelets. J Clin Invest 78: 310-318, 1986.
12. Joseph K, Ghebrehiwet B, and Kaplan AP. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol 92: 246-255, 1999.
13. Joseph K, Ghebrehiwet B, and Kaplan AP. Activation of the kinin-forming cascade on the surface of endothelial cells. Biol Chem 382: 71-75, 2001.
14. Joseph K, Tholanikunnel BG, and Kaplan AP. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci USA 99: 896-900, 2002.
15. Kaplan AP, Joseph K, and Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109: 195-209, 2002.
16. Koshelnick Y, Ehart M, Stockinger H, and Binder BR. Mechanisms of signaling through urokinase receptor and the cellular response. Thromb Haemost 82: 305-311, 1999.
17. Liebmann C. Bradykinin signalling to MAP kinase: cell-specific connections versus principle mitogenic pathways. Biol Chem 382: 49-55, 2001.
18. Mahdi F, Madar ZS, Figueroa CD, and Schmaier AH. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99: 3585-3596, 2002.
19. Mandle RJ Jr, Colman RW, and Kaplan AP. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 73: 4179-4183, 1976.
20. Nishikawa K, Reddigari SR, Silverberg M, Kuna PB, Yago H, Nagaki Y, Toyomaki Y, Suehiro S, and Kaplan AP. Effect of neurotropin on the activation of the plasma kallikrein-kinin system. Biochem Pharmacol 43: 1361-1369, 1992.
21. Oza N, Schwartz JH, Goud GH, and Levinsky NG. Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J Clin Invest 85: 597-600, 1990.
22. Ross R and Glomset JA. Atherosclerosis and the arterial smooth muscle: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180: 1332-1339, 1973.
23. Schmaier AH, Kuo A, Lundberg D, Murray S, and Cines DB. The expression of high molecular weight kininogen on human umbilical vein endothelial cells. J Biol Chem 263: 16327-16333, 1988.
24. Schmeidler-Sapiro KT, Ratnoff OD, and Gordon EM. Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. Proc Natl Acad Sci USA 88: 4382-4385, 1991.
25. Shariat-Madar Z, Mahdi F, and Schmaier AH. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 277: 17962-17969, 2002.
26. Siverberg M and Kaplan AP. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII). Blood 60: 64-70, 1982.
27. Silverberg M, Nicoll JE, and Kaplan AP. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Thromb Res: 20: 173-189, 1980.
28. Tanaka H, Sukhova G, Schwartz D, and Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-α but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 16: 12-18, 1996.
29. Tans G, Rosing J, Berrettini M, Lammle B, and Griffin JH. Autoactivation of human plasma prekallikrein. J Biol Chem 262: 11308-11314, 1987.
30. Vallee BL, Wacker WE, Bartholomay AF, and Hoch FL. Zinc metabolism in hepatic dysfunction. Ann Intern Med 50: 1077-1091, 1959.
31. Van Iwaarden F, de Groot PG, and Bouma BN. The binding of high molecular weight kininogen to cultured human endothelial cells. J Biol Chem 263: 4698-4703, 1988.
32. Velarde V, Ullian ME, Morinelli TA, Mayfield RK, and Jaffa AA. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol Cell Physiol 277: C253-C261, 1999.
33. Wachtfogel YT, DeLa Cadena RA, Kunapuli SP, Rick L, Miller M, Schultze RL, Altieri DC, Edgington TS, and Colman RW. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J Biol Chem 269: 19307-19312, 1994.
34. Zhao Y, Qiu Q, Mahdi F, Shariat-Madar Z, Rojkjaer R, and Schmaier AH. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Am J Physiol Heart Circ Physiol 280: H1821-H1829, 2001.